Bibliographic Details
| Title: |
Plasma Citrate and Succinate Are Associated With Neurocognitive Impairment in Older People With HIV. |
| Authors: |
Hileman, Corrilynn O, Kalayjian, Robert C, Azzam, Sausan, Schlatzer, Daniela, Wu, Kunling, Tassiopoulos, Katherine, Bedimo, Roger, Ellis, Ronald J, Erlandson, Kristine M, Kallianpur, Asha, Koletar, Susan L, Landay, Alan L, Palella, Frank J, Taiwo, Babafemi, Pallaki, Muralidhar, Hoppel, Charles L |
| Source: |
Clinical Infectious Diseases; Aug2021, Vol. 73 Issue 3, pe765-e772, 8p |
| Subject Terms: |
COGNITION disorder risk factors, HIV-positive persons, RESEARCH, WALKING speed, AGE distribution, LIQUID chromatography, CITRATES, MEDICAL cooperation, REGRESSION analysis, RISK assessment, NEUROPSYCHOLOGICAL tests, MASS spectrometry, DESCRIPTIVE statistics, DISEASE prevalence, ACYCLIC acids, LOGISTIC regression analysis, ODDS ratio, LONGITUDINAL method |
| Abstract: |
Background Neurocognitive impairment (NCI) is associated with monocyte activation in people with HIV (PWH). Activated monocytes increase glycolysis, reduce oxidative phosphorylation, and accumulate citrate and succinate, tricarboxylic acid (TCA) cycle metabolites that promote inflammation—this metabolic shift may contribute to NCI and slowed gait speed in PWH. Methods Plasma citrate and succinate were assayed by liquid chromatography–mass spectrometry from 957 participants upon entry to a multicenter, prospective cohort of older PWH. Logistic, linear, and mixed-effects linear regression models were used to examine associations between entry/baseline TCA cycle metabolites and cross-sectional and longitudinal NCI, neuropsychological test scores (NPZ-4), and gait speed. Results Median age was 51 (range 40–78) years. Each 1 standard deviation (SD) citrate increment was associated with 1.18 higher odds of prevalent NCI at baseline (P =.03), 0.07 SD lower time-updated NPZ-4 score (P =.01), and 0.02 m/s slower time-updated gait speed (P <.0001). Age accentuated these effects. In the oldest age-quartile, higher citrate was associated with 1.64 higher odds of prevalent NCI, 0.17 SD lower NPZ-4, and 0.04 m/s slower gait speed (P ≤.01 for each). Similar associations were apparent with succinate in the oldest age-quintile, but not with gait speed. In participants without NCI at entry, higher citrate predicted a faster rate of neurocognitive decline. Conclusions Higher plasma citrate and succinate are associated with worse cross-sectional and longitudinal measures of neurocognitive function and gait speed that are age-dependent, supporting the importance of altered bioenergetic metabolism in the pathogenesis of NCI in older PWH. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
